- Home
- AEE vs WAT Comparison
AEE vs WAT Comparison
Compare AEE & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEE
- WAT
- Stock Information
- Founded
- AEE 1901
- WAT 1958
- Country
- AEE United States
- WAT United States
- Employees
- AEE N/A
- WAT N/A
- Industry
- AEE Power Generation
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- AEE Utilities
- WAT Industrials
- Exchange
- AEE Nasdaq
- WAT Nasdaq
- Market Cap
- AEE 26.0B
- WAT 20.8B
- IPO Year
- AEE N/A
- WAT 1995
- Fundamental
- Price
- AEE $95.72
- WAT $289.69
- Analyst Decision
- AEE Buy
- WAT Hold
- Analyst Count
- AEE 11
- WAT 15
- Target Price
- AEE $100.91
- WAT $379.27
- AVG Volume (30 Days)
- AEE 1.6M
- WAT 696.1K
- Earning Date
- AEE 07-31-2025
- WAT 08-04-2025
- Dividend Yield
- AEE 2.96%
- WAT N/A
- EPS Growth
- AEE 3.54
- WAT 8.23
- EPS
- AEE 4.51
- WAT 11.02
- Revenue
- AEE $7,596,000,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- AEE $13.04
- WAT $6.11
- Revenue Next Year
- AEE $5.42
- WAT $6.44
- P/E Ratio
- AEE $21.29
- WAT $26.15
- Revenue Growth
- AEE 9.04
- WAT 2.57
- 52 Week Low
- AEE $72.33
- WAT $287.62
- 52 Week High
- AEE $104.10
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- AEE 48.59
- WAT 23.06
- Support Level
- AEE $94.20
- WAT $343.83
- Resistance Level
- AEE $97.09
- WAT $360.00
- Average True Range (ATR)
- AEE 1.36
- WAT 12.04
- MACD
- AEE 0.11
- WAT -5.40
- Stochastic Oscillator
- AEE 52.70
- WAT 3.35
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.